Search Browse Earnings

aTYR PHARMA INC — SlamSEC

aTYR PHARMA INC

Nasdaq:ATYR

Biological Products, (No Diagnostic Substances)·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$353,000

-96.6% YoY

FY 2025

Adj. EBITDA

-$54.3M

-15390.1% margin

FY 2025

Net Income

-$50.4M

-14274.5% margin

FY 2025

EPS (Diluted)

-$0.94

FY 2025

Stock Price

$0.85

-5.8%

2026-03-09

52W Range

$0.64 – $7.29

P/E Ratio

-0.9x

Market Cap

$83.2M

Cash

$22.5M

FY 2025

Total Debt

$8.3M

FY 2019

Net Cash

$14.3M

FY 2019

Enterprise Value

$69.0M

Debt / EBITDA

0.3x

FY 2025

EV / EBITDA

-1.3x

Employees

—